Specifically, SCFAs have been shown to enhance the functions of CD8+ T cell through inhibiting histone deacetylase (HDAC) and upregulating effector molecules, contributing to anti-tumor immune responses, particularly in colorectal cancer and gastric cancer (26–29). The gene discussed is CD8A; the disease is neoplasm.